| |
| |
|
| Insider
Information: |
Mahadevia Ankit |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
744,997 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,087,696 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
744,997 |
|
|
| Total
Value |
$1,087,696 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -33.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Spero Therapeutics Inc |
SPRO |
|
2024-02-02 |
744,997 |
2018-07-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SPRO |
Spero Therapeutics Inc |
|
– • – |
2024-02-02 |
4 |
S |
$1.37 |
$87,399 |
D/D |
(63,795) |
744,997 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
|
– • – |
2023-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
808,792 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
|
– • – |
2023-08-28 |
4 |
S |
$1.26 |
$11,390 |
D/D |
(9,040) |
788,792 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2023-02-03 |
4 |
S |
$1.81 |
$22,238 |
D/D |
(12,286) |
797,832 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
531,914 |
810,118 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
134,168 |
278,204 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2021-12-27 |
4 |
OE |
$5.90 |
$47,200 |
D/D |
8,000 |
152,036 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2021-12-27 |
4 |
AS |
$14.58 |
$116,666 |
D/D |
(8,000) |
144,036 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
78,219 |
144,036 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-11-04 |
4 |
AS |
$14.43 |
$106,335 |
D/D |
(7,370) |
65,817 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-11-04 |
4 |
OE |
$5.90 |
$43,483 |
D/D |
7,370 |
73,187 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-11-03 |
4 |
AS |
$14.27 |
$30,490 |
D/D |
(2,137) |
65,817 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-11-03 |
4 |
OE |
$5.90 |
$12,608 |
D/D |
2,137 |
67,954 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-10-23 |
4 |
AS |
$14.25 |
$285 |
D/D |
(20) |
65,817 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-10-23 |
4 |
OE |
$5.90 |
$118 |
D/D |
20 |
65,837 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-10-14 |
4 |
AS |
$14.25 |
$1,496 |
D/D |
(105) |
65,817 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-10-14 |
4 |
OE |
$5.90 |
$620 |
D/D |
105 |
65,922 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-10-13 |
4 |
AS |
$14.28 |
$205,212 |
D/D |
(14,367) |
65,817 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-10-13 |
4 |
OE |
$5.90 |
$84,765 |
D/D |
14,367 |
80,184 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-09-08 |
4 |
AS |
$14.25 |
$11,030 |
D/D |
(774) |
65,817 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-09-08 |
4 |
OE |
$5.90 |
$4,567 |
D/D |
774 |
66,591 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-07-09 |
4 |
OE |
$5.90 |
$13,529 |
D/D |
2,293 |
68,110 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-07-09 |
4 |
AS |
$14.31 |
$32,807 |
D/D |
(2,293) |
65,817 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-07-07 |
4 |
AS |
$14.25 |
$10,745 |
D/D |
(754) |
65,817 |
0 |
% |
|
| SPRO |
Spero Therapeutics Inc |
CEO and President |
• • – |
2020-07-07 |
4 |
OE |
$5.90 |
$4,449 |
D/D |
754 |
66,571 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
